Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Postma

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 18, 2012
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysisM H Rozenbaum, P Pechlivanoglou, T S van der Werf, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 11, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]M J Postma, R Welte, J A van den Hoek, et al.
Respiratory Medicine|December 22, 1999
Current and future medical costs of asthma and chronic obstructive pulmonary disease in The NetherlandsM P Rutten-van Mölken, M J Postma, M A Joore, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]M J Postma, R Welte, J A van den Hoek, et al.
Pharmacy World & Science : PWS|May 1, 2002
Cost-effectiveness of periconceptional supplementation of folic acidM J Postma, J Londeman, M Veenstra, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia TrachomatisM J Postma, R Welte, J A van den Hoek, et al.
Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.
Epidemiology and Infection|March 15, 2018
Quantifying the impact of mass vaccination programmes on notified cases in the NetherlandsM van Wijhe, A D Tulen, H Korthals Altes, et al.
Alimentary Pharmacology & Therapeutics|May 16, 2006
Switch patterns before and after patent expiry of omeprazole: a case study in The NetherlandsR M Klok, C Boersma, I Oosterhuis, et al.
Reproductive Biomedicine Online|December 25, 2013
Costs and benefits of individuals conceived after IVF: a net tax evaluation in The NetherlandsL M Moolenaar, M Connolly, B Huisman, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 18, 2012
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysisM H Rozenbaum, P Pechlivanoglou, T S van der Werf, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 11, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]M J Postma, R Welte, J A van den Hoek, et al.
Respiratory Medicine|December 22, 1999
Current and future medical costs of asthma and chronic obstructive pulmonary disease in The NetherlandsM P Rutten-van Mölken, M J Postma, M A Joore, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]M J Postma, R Welte, J A van den Hoek, et al.
Pharmacy World & Science : PWS|May 1, 2002
Cost-effectiveness of periconceptional supplementation of folic acidM J Postma, J Londeman, M Veenstra, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 14, 2001
Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia TrachomatisM J Postma, R Welte, J A van den Hoek, et al.
Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.
Epidemiology and Infection|March 15, 2018
Quantifying the impact of mass vaccination programmes on notified cases in the NetherlandsM van Wijhe, A D Tulen, H Korthals Altes, et al.
Alimentary Pharmacology & Therapeutics|May 16, 2006
Switch patterns before and after patent expiry of omeprazole: a case study in The NetherlandsR M Klok, C Boersma, I Oosterhuis, et al.
Reproductive Biomedicine Online|December 25, 2013
Costs and benefits of individuals conceived after IVF: a net tax evaluation in The NetherlandsL M Moolenaar, M Connolly, B Huisman, et al.
Pageof 14